What Clinical Trials Can Teach Us about the Development of More Resilient AI for Cybersecurity

05/13/2021

∙

by   Edmon Begoli, et al.

∙

0

∙

share

Policy-mandated, rigorously administered scientific testing is needed to provide transparency into the efficacy of artificial intelligence-based (AI-based) cyber defense tools for consumers and to prioritize future research and development. In this article, we propose a model that is informed by our experience, urged forward by massive scale cyberattacks, and inspired by parallel developments in the biomedical field and the unprecedentedly fast development of new vaccines to combat global pathogens.